OXFORD BIOMEDICA PLC (OXB.L)

5.24GBP -0.57% (-0.03)

Over 6M: -18.8%

2026-08-28
5 6
Mar Apr May Jun Jul Aug

Figures as at 2025-12-31, reported in GBP. The newest fact in the filings is dated 2026-01-01, 240 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

2.4
OE margin -2.5%
Oper. margin -13.3%
ROIC -49.4%
Gross margin 39.1%
FCF margin -2.5%
OCF margin 0.3%
Profit margin -18.2%
ROE -33.5%
Accruals —
Asset turnover —
EBITDA margin —
OCF / EBIT —
ROA —
ROCE —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.6
EV/Sales 3.1×
EV/OE -124.8×
P/C 6.1×
EV/GP 8.0×
P/B 6.4×
FCF yield -0.73%
Div. yield —
EV/EBIT —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

0.5
RPO / sales —
RPO growth —
Segment HHI —

0 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

5.6
ND/EBITDA 0.1
Cash / Debt 2.3×
Cash runway 13.0 yr
Debt payback 0.0 yr
Quick ratio 2.0×
Debt / Eq 0.45×
Equity / Assets —
F-score —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

5.1
Sales/sh Y/Y +31.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —
Shares change —

1 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.